The Clinical Significance of Endocannabinoids in Endometriosis Pain Management

Patients with endometriosis often suffer from diffuse and poorly localized severe pain. The current pain management strategies include medical and hormonal therapy, as well as surgery. Medical management of pain is often insufficient and is associated with high rate of recurrence. Better pain management is therefore of urgent need.
Among the various candidates, the endocannabinoid system (ECS) has recently emerged as a relevant pharmacological target for the management of endometriosis-related pain.

The post The Clinical Significance of Endocannabinoids in Endometriosis Pain Management appeared first on Weed World Magazine.